Literature DB >> 10523316

TRF1 binds a bipartite telomeric site with extreme spatial flexibility.

A Bianchi1, R M Stansel, L Fairall, J D Griffith, D Rhodes, T de Lange.   

Abstract

TRF1 is a key player in telomere length regulation. Because length control was proposed to depend on the architecture of telomeres, we studied how TRF1 binds telomeric TTAGGG repeat DNA and alters its conformation. Although the single Myb-type helix-turn-helix motif of a TRF1 monomer can interact with telomeric DNA, TRF1 predominantly binds as a homodimer. Systematic Evolution of Ligands by Exponential enrichment (SELEX) with dimeric TRF1 revealed a bipartite telomeric recognition site with extreme spatial variability. Optimal sites have two copies of a 5'-YTAGGGTTR-3' half-site positioned without constraint on distance or orientation. Analysis of binding affinities and DNase I footprinting showed that both half-sites are simultaneously contacted by the TRF1 dimer, and electron microscopy revealed looping of the intervening DNA. We propose that a flexible segment in TRF1 allows the two Myb domains of the homodimer to interact independently with variably positioned half-sites. This unusual DNA binding mode is directly relevant to the proposed architectural role of TRF1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523316      PMCID: PMC1171640          DOI: 10.1093/emboj/18.20.5735

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  89 in total

1.  Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.

Authors:  Katia Ancelin; Michele Brunori; Serge Bauwens; Catherine-Elaine Koering; Christine Brun; Michelle Ricoul; Jean-Patrick Pommier; Laure Sabatier; Eric Gilson
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 2.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 3.  Telomere architecture.

Authors:  Daniela Rhodes; Louise Fairall; Tomas Simonsson; Robert Court; Lynda Chapman
Journal:  EMBO Rep       Date:  2002-12       Impact factor: 8.807

4.  Tay1 protein, a novel telomere binding factor from Yarrowia lipolytica.

Authors:  Juraj Kramara; Smaranda Willcox; Stanislava Gunisova; Slavomir Kinsky; Jozef Nosek; Jack D Griffith; Lubomir Tomaska
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

5.  The role of intercalating residues in chromosomal high-mobility-group protein DNA binding, bending and specificity.

Authors:  Janet Klass; Frank V Murphy; Susan Fouts; Melissa Serenil; Anita Changela; Jessica Siple; Mair E A Churchill
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

6.  Transcriptional Repressor CopR: use of SELEX to study the copR operator indicates that evolution was directed at maximal binding affinity.

Authors:  Peggy Freede; Sabine Brantl
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

7.  Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats.

Authors:  Rieko Ohki; Fuyuki Ishikawa
Journal:  Nucleic Acids Res       Date:  2004-03-08       Impact factor: 16.971

8.  Telomere proteins POT1, TRF1 and TRF2 augment long-patch base excision repair in vitro.

Authors:  Adam S Miller; Lata Balakrishnan; Noah A Buncher; Patricia L Opresko; Robert A Bambara
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

9.  POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.

Authors:  Dirk Hockemeyer; Agnel J Sfeir; Jerry W Shay; Woodring E Wright; Titia de Lange
Journal:  EMBO J       Date:  2005-06-23       Impact factor: 11.598

10.  The human telomere-associated protein TIN2 stimulates interactions between telomeric DNA tracts in vitro.

Authors:  Sahn-Ho Kim; Seungil Han; Young-Hyun You; David J Chen; Judith Campisi
Journal:  EMBO Rep       Date:  2003-07       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.